Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

HRT more effective than raloxifene in improving heart disease risk factors

May 13, 1998

Promising new TMR data presented at scientific meeting

May 13, 1998

Merck KGaA, Yamanouchi to codevelop two new cardiovascular drug candidates

May 13, 1998

MK-886 demonstrates antihyperplastic activity in an animal model of intimal thickening

May 13, 1998

Azimilide: a unique new antiarrhythmic agent in phase III development

May 12, 1998

Roche and Nortran join forces for development of atrial arrhythmia drugs

May 11, 1998

Proteus seeks partners, licensees for novel hypertension vaccine

May 8, 1998

Roche now copromoting Coreg with SKB

May 8, 1998

E-4010: a potential new treatment for pulmonary hypertension

May 8, 1998

Scios submits NDA for Natrecor

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...